This company seems to have been delisted
Reason: Acquired by Mars, Incorporated
Last recorded trade on: August 15, 2023
Source: https://www.mars.com/news-and-stories/press-releases-statements/mars-to-acquire-heska-global-provider-advanced-veterinary-solutions
Reason: Acquired by Mars, Incorporated
Last recorded trade on: August 15, 2023
Source: https://www.mars.com/news-and-stories/press-releases-statements/mars-to-acquire-heska-global-provider-advanced-veterinary-solutions
Heska Corporation
HSKA
HK$941.84
Share price
0.00%
Change (1 day)
30.41%
Change (1 year)
Categories
Heska Corporation (HSKA) - Net assets
Net assets on the balance sheet as of March 2023 : HK$3.27 Billion
According to Heska Corporation
's latest financial reports the company has HK$3.27 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Heska Corporation - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $HK$3.29 B | -2.94% |
| 2021-12-31 | $HK$3.39 B | 52.73% |
| 2020-12-31 | $HK$2.22 B | 85.1% |
| 2019-12-31 | $HK$1.20 B | 25.42% |
| 2018-12-31 | $HK$0.95 B | 22.15% |
| 2017-12-31 | $HK$0.78 B | 16.35% |
| 2016-12-31 | $HK$0.67 B | 36.98% |
| 2015-12-31 | $HK$0.49 B | 19.48% |
| 2014-12-31 | $HK$0.41 B | 12.8% |
| 2013-12-31 | $HK$0.36 B | -3.53% |
| 2012-12-31 | $HK$0.37 B | 0.67% |
| 2011-12-31 | $HK$0.37 B | 5.56% |
| 2010-12-31 | $HK$0.35 B | 2.02% |
| 2009-12-31 | $HK$0.34 B | 6.31% |
| 2008-12-31 | $HK$0.32 B | -1.72% |
| 2007-12-31 | $HK$0.33 B | 537.09% |
| 2006-12-31 | $HK$52.48 M | 109.37% |
| 2005-12-31 | $HK$25.06 M | 25.07% |
| 2004-12-31 | $HK$20.04 M | -61.15% |
| 2003-12-31 | $HK$51.59 M | -28.17% |
| 2002-12-31 | $HK$71.82 M | -46.34% |
| 2001-12-31 | $HK$0.13 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 IDEXX Laboratories IDXX | HK$11.36 B | 246.69% | 🇺🇸 USA |
 Eli Lilly LLY | HK$124.38 B | 3,694.09% | 🇺🇸 USA |
 Petco WOOF | HK$8.69 B | 165.12% | 🇺🇸 USA |
 Pfizer PFE | HK$711.43 B | 21,600.57% | 🇺🇸 USA |
 Merck MRK | HK$379.90 B | 11,488.07% | 🇺🇸 USA |
 Novartis NVS | HK$301.82 B | 9,106.29% | 🇨🇭 Switzerland |
 Zoetis ZTS | HK$36.53 B | 1,014.51% | 🇺🇸 USA |